These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27620886)

  • 21. Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.
    Själander S; Svensson PJ; Friberg L
    Int J Cardiol; 2016 Jul; 215():360-3. PubMed ID: 27128562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study.
    Overvad TF; Skjøth F; Lip GY; Lane DA; Albertsen IE; Rasmussen LH; Larsen TB
    Stroke; 2015 Aug; 46(8):2168-74. PubMed ID: 26152296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of warfarin in elderly patients with non-valvular atrial fibrillation -- subanalysis of the J-RHYTHM Registry.
    Kodani E; Atarashi H; Inoue H; Okumura K; Yamashita T; Origasa H;
    Circ J; 2015; 79(11):2345-52. PubMed ID: 26329097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation. Subanalysis of the J-RHYTHM Registry.
    Inoue H; Atarashi H; Okumura K; Yamashita T; Kumagai N; Origasa H
    Circ J; 2014; 78(10):2388-93. PubMed ID: 25099606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry.
    Königsbrügge O; Simon A; Domanovits H; Pabinger I; Ay C
    BMC Cardiovasc Disord; 2016 Dec; 16(1):254. PubMed ID: 27938343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Impact of history of hypertension and blood pressure levels on the risk of thromboembolism in nonvalvular atrial fibrillation patients].
    Zhu HJ; Jiang C; Kong XY; He L; Wang YF; Luo ZF; Xia SJ; Du X; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):721-727. PubMed ID: 32957753
    [No Abstract]   [Full Text] [Related]  

  • 27. Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Clementy N; Haguenoer K; Fauchier L; Lip GY
    Am J Med; 2014 Oct; 127(10):972-8. PubMed ID: 24929021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Impact of Asymptomatic Presentation Status in Patients With Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry.
    Esato M; Chun YH; An Y; Ogawa H; Wada H; Hasegawa K; Tsuji H; Abe M; Lip GYH; Akao M
    Chest; 2017 Dec; 152(6):1266-1275. PubMed ID: 28823813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation.
    Barrios V; Escobar C; Prieto Valiente L; Lobos JM; Vargas-Ortega D; Polo J; Marin Montañés N
    Blood Press; 2017 Oct; 26(5):279-283. PubMed ID: 28385080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study.
    Li ZZ; Du X; Liu N; Guo XY; Jiang C; He L; Xia SJ; Wang W; Tang RB; Chang SS; Yu RH; Long DY; Bai R; Sang CH; Li SN; Dong JZ; Ma CS
    Med Sci Monit; 2022 Apr; 28():e934747. PubMed ID: 35418552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
    Avezum A; Lopes RD; Schulte PJ; Lanas F; Gersh BJ; Hanna M; Pais P; Erol C; Diaz R; Bahit MC; Bartunek J; De Caterina R; Goto S; Ruzyllo W; Zhu J; Granger CB; Alexander JH
    Circulation; 2015 Aug; 132(8):624-32. PubMed ID: 26106009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CHA
    Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
    Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The impact of hypertension history and baseline blood pressure levels on the cardiovascular outcomes in Chinese emergency atrial fibrillation patients].
    Wang J; Yang YM; Zhu J; Zhang H; Shao XH; Tian L; Huang B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):911-5. PubMed ID: 24370216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large-scale prospective, real-world observational study.
    Kario K; Saito I; Kushiro T; Teramukai S; Ishikawa Y; Mori Y; Kobayashi F; Shimada K
    Hypertension; 2014 Nov; 64(5):989-96. PubMed ID: 25156169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
    Steinberg BA; Peterson ED; Kim S; Thomas L; Gersh BJ; Fonarow GC; Kowey PR; Mahaffey KW; Sherwood MW; Chang P; Piccini JP; Ansell J;
    Circulation; 2015 Feb; 131(5):488-94. PubMed ID: 25499873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system.
    Darkow T; Vanderplas AM; Lew KH; Kim J; Hauch O
    Curr Med Res Opin; 2005 Oct; 21(10):1583-94. PubMed ID: 16238898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.